Rocket Lab (RKLB) did almost everything right in the second quarter. It posted record revenue that beat expectations, narrowed its loss, lifted its backlog by 137%, guided to yet another record quarter, and announced a transformational acquisition. The stock fell about 10%.
That gap, between a strong report and a sharp sell-off, is the story. RKLB shares had rallied more than 40% in the seven sessions before the print, pushing the company toward a $50 billion valuation and pricing in something close to perfection. When the results came in merely very good, with cash burn still heavy and its Neutron rocket’s first-flight window narrowing, the market sold the difference. Shares fell to roughly $74.60 after hours and opened the next session softer still, near $72.
Rocket Lab (RKLB) fell about 10% after its Q2 report, giving back much of a 40%-plus rally that had run into the print. Source: TradingViewThe Results Were Strong
Start with what Rocket Lab actually delivered, because on the numbers it was a good quarter. The company reported record revenue of $234.1 million, up 62% year over year and 16.8% sequentially, beating the roughly $231 million consensus. The net loss narrowed to $49.3 million, or $0.08 a share, from $66.4 million, or $0.13, a year earlier. Backlog reached a record $2.36 billion, up 137% year over year, and the company said it had already signed more than $1 billion in new contracts in the third quarter across its launch and space-systems businesses.
Rocket Lab’s (RKLB) Q2 loss of $0.08 a share came in essentially in line with estimates, confirming that the sell-off was not about earnings. Source: Rocket Lab SEC filingAdjusted EBITDA told an even better story: a loss of just $8.8 million, dramatically better than the $20 million to $26 million loss the company had guided to. And Rocket Lab guided third-quarter revenue to $250 million to $265 million, which would be another record. Space Systems revenue reached $189.5 million, up nearly 39% sequentially, boosted by satellite manufacturing and an initial contribution from the recently acquired Mynaric. By almost any conventional measure, this was a beat-and-raise.
Why RKLB Sold Off Anyway
The RKLB stock sell-off was about expectations, not execution. After a 41% run-up, the bar was no longer the published consensus; it was the rally itself, and a modest beat could not clear it. Investors then focused on the concerns the strong headline had briefly obscured.
Chief among them was cash. Rocket Lab is spending heavily on Neutron development, manufacturing expansion, and now a string of acquisitions, and free cash flow is expected to stay negative for an extended period. The company has a $2.4 billion cash cushion, but the market is increasingly asking when the growth-at-all-costs phase gives way to profitability, and this quarter did not answer it.
Gross-margin guidance softened for the third quarter, and the forward share count includes roughly 41 million preferred shares, a dilution overhang for existing holders. A strong quarter with a fuzzy path to profit is exactly the kind of report a richly valued stock struggles to sustain.
Investor Takeaway
The drop was a valuation reset, not an earnings miss: a 41% pre-print rally priced in perfection, so a strong-but-not-flawless quarter had nowhere to go but down.
Neutron: The Milestone That Matters Most
For Rocket Lab, the single most important variable is not this quarter’s revenue but the first flight of Neutron, the medium-lift reusable rocket meant to move the company from small-satellite launches into the far larger market that mega-constellations require. Our own earnings preview flagged Neutron as the real test, and the update was progress with a caveat.
Rocket Lab said Neutron’s first-stage tank is targeting delivery to the launch pad in the fourth quarter of 2026, but acknowledged the year-end launch window is narrowing. That is the phrase that matters: not a slip, but a tightening, and for a stock priced on Neutron flying on schedule, a narrowing window reads as risk.
The demand side, at least, is strengthening. “Customers know we develop and scale reliable launch vehicles, which is why they are coming to us now and locking in Neutron slots early,” CEO Peter Beck said, and the company has already signed dedicated Neutron missions for the Space Force’s moving-target program and for Kepler Communications. The $397 million Space Force contract for the Space-Based Airborne Moving Target Indicator program, awarded after quarter-end, is slated to fly on Neutron.
The Iridium Deal and the Vertical-Integration Push
Alongside earnings, Rocket Lab announced an agreement to acquire Iridium Communications, a deal it framed as creating a fully vertically integrated space company spanning launch, spacecraft manufacturing and satellite communications. It follows the recently closed acquisitions of Mynaric and Motiv, making Iridium the third major deal in Rocket Lab’s push to own more of the space value chain.
The logic mirrors a pattern across the sector, where space companies are buying their way into new capabilities rather than building them, much as Archer just acquired three Boeing businesses the same night. But acquisitions add integration risk and cash demands on top of Neutron’s, which is part of why the market’s enthusiasm was tempered. A vertically integrated space powerhouse is a compelling long-term story; it is also an expensive one to assemble while a flagship rocket is still working toward its first flight.
Where It Sits in the Space Trade
Rocket Lab reported the same night as AST SpaceMobile and Archer Aviation, and all three space stocks fell on results, a fitting end to a summer in which the sector rallied hard then gave much of it back. Space stocks had surged in early August as the “SpaceX Effect” that dragged them down in July reversed, and RKLB was among the biggest beneficiaries, up more than 40% into its print. That rally is precisely what made the quarter so hard to live up to.
The longer-term case is intact. Rocket Lab has a record backlog, a strengthening defense franchise, a clear vertical-integration strategy, and a rocket that, if it flies, opens a far larger market. For how the range of outcomes maps to the share price, FinanceFeeds’ Rocket Lab (RKLB) forecast frames a bull case at $293, a base case at $111 and a bear case at $76. The quarter did not change that map. What it changed was the market’s willingness to pay for perfection before Neutron has left the ground.
Investor Takeaway
Neutron’s narrowing year-end launch window is the key risk to watch, since the RKLB stock’s valuation leans heavily on the rocket flying on schedule.